Last Published 01.01.2026 Effective Date: 01.01.2026 This policy addresses dermal filler injections and injectable bulking agents
Niacinamide-containing facial moisturizer improves barrier and hydration
This property is utilized to explore copper-dependent regulation of ECM synthesis and remodeling, as well as copper-sensitive oxidative stress pathways
This results in increased unstable iron pools and promoted lipid peroxidation
Finasteride, a 5-alpha reductase inhibitor that reduces DHT production, addresses the hormonal component of androgenetic alopecia but carries a well-documented profile of systemic side effects including sexual dysfunction, mood disturbance, and in a subset of patients persistent post-treatment syndrome
GLP-1 medications are typically intended for individuals with a BMI of 30 or higher, or 27 with a weight-related health condition